Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Glutathione-S-transferase family of enzymes.
|
Mutat Res
|
2001
|
2.74
|
2
|
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene.
|
J Invest Dermatol
|
1998
|
2.37
|
3
|
The glutathione S-transferases: influence of polymorphism on cancer susceptibility.
|
IARC Sci Publ
|
1999
|
1.60
|
4
|
Glutathione S-transferase: genetics and role in toxicology.
|
Toxicol Lett
|
2000
|
1.59
|
5
|
Non-melanoma skin cancer risk in the Queensland renal transplant population.
|
Br J Dermatol
|
2002
|
1.54
|
6
|
Epigenetic control of fetal gene expression.
|
BJOG
|
2007
|
1.51
|
7
|
Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer.
|
Lancet
|
2001
|
1.42
|
8
|
The development of glutathione S-transferase and glutathione peroxidase activities in human lung.
|
Biochim Biophys Acta
|
1986
|
1.30
|
9
|
Glutathione S-transferase polymorphisms in MS: their relationship to disability.
|
Neurology
|
2000
|
1.30
|
10
|
GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis.
|
Gut
|
1993
|
1.30
|
11
|
Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers.
|
Carcinogenesis
|
1996
|
1.28
|
12
|
Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
|
Pharmacogenetics
|
1998
|
1.25
|
13
|
Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients.
|
Am J Kidney Dis
|
2000
|
1.24
|
14
|
Basal cell carcinoma.
|
J R Soc Med
|
1998
|
1.20
|
15
|
Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours.
|
Lancet
|
1994
|
1.20
|
16
|
Polymorphisms at the glutathione S-transferase, GSTP1 locus: a novel mechanism for susceptibility and development of atopic airway inflammation.
|
Allergy
|
2000
|
1.19
|
17
|
Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma.
|
Clin Cancer Res
|
2000
|
1.18
|
18
|
Susceptibility to basal cell carcinoma: associations with PTCH polymorphisms.
|
Ann Hum Genet
|
2004
|
1.17
|
19
|
Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations.
|
Biochem J
|
1999
|
1.15
|
20
|
Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21(WAF1/CIP1) expression and correlates with patient survival.
|
Int J Cancer
|
2001
|
1.13
|
21
|
Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice.
|
BMJ
|
2001
|
1.09
|
22
|
Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma.
|
Cancer Res
|
1996
|
1.06
|
23
|
Effects of glutathione S-transferase M1, T1 and P1 on lung function in asthmatic families.
|
Clin Exp Allergy
|
2005
|
1.06
|
24
|
Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients.
|
J R Soc Med
|
1997
|
1.06
|
25
|
Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci.
|
Carcinogenesis
|
1999
|
1.06
|
26
|
Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual.
|
Carcinogenesis
|
1996
|
1.03
|
27
|
Association of polymorphism in glutathione S-transferase loci with susceptibility and outcome in rheumatoid arthritis: comparison with the shared epitope.
|
Ann Rheum Dis
|
1999
|
1.01
|
28
|
Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients.
|
Transplant Proc
|
2001
|
1.00
|
29
|
Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population.
|
Brain
|
2004
|
1.00
|
30
|
The human glutathione S-transferases: comparison of isoenzyme expression in normal and astrocytoma brain.
|
Biochim Biophys Acta
|
1992
|
1.00
|
31
|
Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity.
|
J Neuroimmunol
|
2002
|
1.00
|
32
|
Multiple basal cell carcinomas and malignant melanoma following radiotherapy for ankylosing spondylitis.
|
Clin Exp Dermatol
|
2000
|
0.99
|
33
|
Glutathione S-transferase polymorphisms: influence on susceptibility to cancer.
|
Chem Biol Interact
|
1998
|
0.98
|
34
|
Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
|
Am J Pathol
|
2001
|
0.98
|
35
|
Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
|
Clin Cancer Res
|
1998
|
0.97
|
36
|
Detoxifying enzyme genotypes and susceptibility to cutaneous malignancy.
|
Br J Dermatol
|
2000
|
0.96
|
37
|
Genetics and risk factors for basal cell carcinoma.
|
Br J Dermatol
|
2006
|
0.95
|
38
|
Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes.
|
Neurology
|
2004
|
0.95
|
39
|
Glutathione S-transferase in human brain.
|
Neuropathol Appl Neurobiol
|
1990
|
0.94
|
40
|
Asthma severity and atopy: how clear is the relationship?
|
Arch Dis Child
|
2006
|
0.94
|
41
|
Simultaneous identification of GSTP1 Ile105-->Val105 and Ala114-->Val114 substitutions using an amplification refractory mutation system polymerase chain reaction assay: studies in patients with asthma.
|
Respir Res
|
2001
|
0.94
|
42
|
Studies on the developmental expression of glutathione S-transferase isoenzymes in human heart and diaphragm.
|
Biochim Biophys Acta
|
1987
|
0.93
|
43
|
Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours.
|
Pharmacogenetics
|
2000
|
0.92
|
44
|
Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells.
|
Br J Cancer
|
1999
|
0.91
|
45
|
Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes.
|
Br J Cancer
|
2001
|
0.91
|
46
|
How should airways resistance be measured in young children: mask or mouthpiece?
|
Eur Respir J
|
2001
|
0.89
|
47
|
Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer.
|
Pharmacogenetics
|
2001
|
0.89
|
48
|
Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck.
|
Cancer
|
2001
|
0.89
|
49
|
Outcome in prostate cancer associations with skin type and polymorphism in pigmentation-related genes.
|
Carcinogenesis
|
2001
|
0.88
|
50
|
Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes.
|
Clin Chim Acta
|
1995
|
0.88
|
51
|
Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis.
|
J Invest Dermatol
|
2001
|
0.88
|
52
|
Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction.
|
J Invest Dermatol
|
1997
|
0.87
|
53
|
Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer.
|
Int J Gynecol Cancer
|
2004
|
0.87
|
54
|
HLA-DRB1 and disease outcome in multiple sclerosis.
|
J Neurol
|
2001
|
0.86
|
55
|
Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomas.
|
Br J Dermatol
|
2000
|
0.86
|
56
|
Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype.
|
Pharmacogenetics
|
2001
|
0.86
|
57
|
Glutathione S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survival.
|
Int J Gynecol Cancer
|
2001
|
0.84
|
58
|
A comparison of risk factors for malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK.
|
Int J Clin Pract
|
1998
|
0.84
|
59
|
Maternal glutathione S-transferase GSTP1 genotype is a specific predictor of phenotype in children with asthma.
|
Pediatr Allergy Immunol
|
2005
|
0.84
|
60
|
The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas.
|
Pharmacogenetics
|
1998
|
0.84
|
61
|
Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma.
|
Carcinogenesis
|
1997
|
0.84
|
62
|
Developmental profile of plasma proteins in human fetal cerebrospinal fluid and blood.
|
Neuropathol Appl Neurobiol
|
1991
|
0.83
|
63
|
Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer.
|
Clin Cancer Res
|
1998
|
0.83
|
64
|
Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6.
|
Pharmacogenetics
|
1998
|
0.83
|
65
|
Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer.
|
Carcinogenesis
|
2005
|
0.82
|
66
|
Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma.
|
Pharmacogenetics
|
1999
|
0.82
|
67
|
GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gsp.
|
Carcinogenesis
|
1995
|
0.82
|
68
|
Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas.
|
Carcinogenesis
|
2001
|
0.82
|
69
|
The melanocyte stimulating hormone receptor polymorphism: association of the V92M and A294H alleles with basal cell carcinoma.
|
Clin Chim Acta
|
1999
|
0.81
|
70
|
Susceptibility and modifier genes in cutaneous basal cell carcinomas and their associations with clinical phenotype.
|
J Photochem Photobiol B
|
2001
|
0.81
|
71
|
The rise and fall of C-reactive protein: managing demand within clinical biochemistry.
|
Ann Clin Biochem
|
2009
|
0.81
|
72
|
Basal cell carcinoma.
|
Cancer
|
2000
|
0.81
|
73
|
Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis.
|
Mult Scler
|
2000
|
0.81
|
74
|
Cyclin D1, glutathione S-transferase, and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis.
|
Cancer Epidemiol Biomarkers Prev
|
1999
|
0.81
|
75
|
[First results on the influence of polymorphisms at glutathione S-transferase, cytochrome P450, and tumor necrosis factor gene loci on the development of multiple head and neck cancer].
|
Laryngorhinootologie
|
2003
|
0.81
|
76
|
Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione s-transferase GSTM1 null genotypes and cigarette smoking.
|
Br J Cancer
|
1994
|
0.80
|
77
|
Lipid peroxidation and expression of copper-zinc and manganese superoxide dismutase in lungs of premature infants with hyaline membrane disease and bronchopulmonary dysplasia.
|
J Lab Clin Med
|
1990
|
0.80
|
78
|
The genetics of asthma: are the glutathione S-transferases serious players?
|
Clin Exp Allergy
|
2007
|
0.80
|
79
|
Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes.
|
Arthritis Rheum
|
2000
|
0.80
|
80
|
Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.
|
Cancer Epidemiol Biomarkers Prev
|
1999
|
0.80
|
81
|
Polymorphism in glutathione S-transferase loci as a risk factor for common cancers.
|
Arch Toxicol Suppl
|
1998
|
0.80
|
82
|
A pilot study of the relationship between gadolinium-enhancing lesions, gender effect and polymorphisms of antioxidant enzymes in multiple sclerosis.
|
J Neurol
|
2000
|
0.80
|
83
|
Novel polymorphism in the promoter region of the human nerve growth-factor gene.
|
Int J Immunogenet
|
2005
|
0.78
|
84
|
The role of polymorphisms of glutathione S-transferases GSTM1, M3, P1, T1 and A1 in susceptibility to alcoholic liver disease.
|
Alcohol Alcohol
|
2004
|
0.78
|
85
|
Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression.
|
Br J Cancer
|
1996
|
0.78
|
86
|
Alpha, mu and pi class glutathione S-transferases in human synovium and cultured synovial fibroblasts: effects of interleukin-1 alpha, hydrogen peroxide and inhibition of eicosanoid synthesis.
|
Free Radic Res Commun
|
1993
|
0.78
|
87
|
Patients with truncal basal cell carcinoma represent a high-risk group.
|
Arch Dermatol
|
1998
|
0.78
|
88
|
Inhaler devices for asthma: do we follow the guidelines?
|
Arch Dis Child
|
2002
|
0.78
|
89
|
Measuring vitamin D levels: surrogates are insufficient.
|
Int J Clin Pract
|
2014
|
0.77
|
90
|
[Initial results of glutathione-S-transferase GSTM1 and GSTT1 genotypes and genetic predisposition for laryngeal carcinoma].
|
Laryngorhinootologie
|
1995
|
0.77
|
91
|
Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes.
|
Clin Exp Dermatol
|
2005
|
0.77
|
92
|
Further support for the association of CCR5 allelic variants with asthma susceptibility.
|
Eur J Immunogenet
|
2002
|
0.77
|
93
|
Regional variation of airway hyperresponsiveness in children with asthma.
|
Respir Med
|
2005
|
0.77
|
94
|
Allelism at the glutathione S-transferase GSTM3 locus: interactions with GSTM1 and GSTT1 as risk factors for astrocytoma.
|
Carcinogenesis
|
1996
|
0.77
|
95
|
Predicting dysglycaemia in patients under investigation for acute coronary syndrome.
|
QJM
|
2010
|
0.77
|
96
|
The therapeutic response to D-penicillamine in rheumatoid arthritis: influence of glutathione S-transferase polymorphisms.
|
Rheumatology (Oxford)
|
1999
|
0.76
|
97
|
Genetic factors determining cutaneous basal cell carcinoma phenotype.
|
Med Pediatr Oncol
|
2001
|
0.76
|
98
|
No association between the APOE epsilon4 allele and outcome and susceptibility in primary progressive multiple sclerosis.
|
J Neurol Neurosurg Psychiatry
|
2000
|
0.76
|
99
|
Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up.
|
Br J Dermatol
|
2006
|
0.75
|
100
|
An association study between the Clara cell secretory protein CC16 A38G polymorphism and asthma phenotypes.
|
Clin Exp Allergy
|
2002
|
0.75
|
101
|
Studies on the expression of Cu,Zn superoxide dismutase in human tissues during development.
|
Biochim Biophys Acta
|
1988
|
0.75
|
102
|
Non-Hodgkins lymphoma and solar ultraviolet radiation. Basal cell carcinoma may be linked to haematological malignancy.
|
BMJ
|
1996
|
0.75
|
103
|
Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation.
|
Mult Scler
|
2007
|
0.75
|
104
|
[Influence of glutathione s-transferase and cytochrome p450 polymorphisms on prognosis of head and neck cancer].
|
Laryngorhinootologie
|
2002
|
0.75
|
105
|
[Immunohistologic and molecular genetic studies of the effect of glutathione-S-transferases on the development of squamous epithelial carcinomas in the area of the head-neck].
|
Laryngorhinootologie
|
1999
|
0.75
|
106
|
[Influence of genetic variation in the major histocompatibility complex on head and neck cancer susceptibility].
|
Laryngorhinootologie
|
2001
|
0.75
|
107
|
Re: relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma.
|
J Natl Cancer Inst
|
1997
|
0.75
|
108
|
Genetic polymorphism and clinical outcome: identification of individuals at risk of a poor clinical outcome.
|
Allergy
|
2000
|
0.75
|